BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 23582673)

  • 21. [Radiofrequency sympathetic renal denervation: a new version of the old method of treatment resistant hypertension].
    Shavarov AA; Maĭskov VV; Kobalava ZhD
    Kardiologiia; 2013; 53(1):72-8. PubMed ID: 23548354
    [No Abstract]   [Full Text] [Related]  

  • 22. Renal Denervation After SYMPLICITY HTN-3: Where Do We Go?
    Briasoulis A; Bakris G
    Can J Cardiol; 2015 May; 31(5):642-8. PubMed ID: 25828371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reflections on renal denervation.
    Demaria AN
    J Am Coll Cardiol; 2014 Apr; 63(14):1452-3. PubMed ID: 24721320
    [No Abstract]   [Full Text] [Related]  

  • 24. Renal denervation for hypertension.
    Bertog SC; Sobotka PA; Sievert H
    JACC Cardiovasc Interv; 2012 Mar; 5(3):249-58. PubMed ID: 22440489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous renal denervation: new treatment option for resistant hypertension and more?
    Ewen S; Ukena C; Böhm M; Mahfoud F
    Heart; 2013 Aug; 99(15):1129-34. PubMed ID: 23418204
    [No Abstract]   [Full Text] [Related]  

  • 26. The rise, fall, and possible resurrection of renal denervation.
    Gulati R; Raphael CE; Negoita M; Pocock SJ; Gersh BJ
    Nat Rev Cardiol; 2016 Apr; 13(4):238-44. PubMed ID: 26843285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SYMPLICITY: not all that simple.
    Luft FC
    Kidney Int; 2014 May; 85(5):999-1001. PubMed ID: 24786869
    [No Abstract]   [Full Text] [Related]  

  • 28. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.
    Kaltenbach B; Franke J; Bertog SC; Steinberg DH; Hofmann I; Sievert H
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):335-9. PubMed ID: 22807098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistant hypertension: is renal denervation the current treatment of choice?
    Reddi AS
    Clin Exp Hypertens; 2014; 36(8):525-30. PubMed ID: 24678737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endovascular treatment of resistant and uncontrolled hypertension: therapies on the horizon.
    Bunte MC; Infante de Oliveira E; Shishehbor MH
    JACC Cardiovasc Interv; 2013 Jan; 6(1):1-9. PubMed ID: 23266234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential new indications and future studies.
    Sudano I; Noll G; Luscher TF
    EuroIntervention; 2013 May; 9 Suppl R():R155-60. PubMed ID: 23732149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study.
    Mahfoud F; Schlaich M; Kindermann I; Ukena C; Cremers B; Brandt MC; Hoppe UC; Vonend O; Rump LC; Sobotka PA; Krum H; Esler M; Böhm M
    Circulation; 2011 May; 123(18):1940-6. PubMed ID: 21518978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal denervation as therapy for hypertension: potentials and unanswered questions.
    Vink EE; Bots ML; Blankestijn PJ
    Eur J Prev Cardiol; 2013 Dec; 20(6):980-91. PubMed ID: 23610453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal denervation in hypertension: Towards a true revival?
    Courand PY; Azizi M; Lantelme P
    Arch Cardiovasc Dis; 2018 Oct; 111(10):541-544. PubMed ID: 30219622
    [No Abstract]   [Full Text] [Related]  

  • 35. Renal denervation in the treatment of drug-resistant hypertension: current knowledge and future perspectives.
    Prochnau D; Figulla HR; Surber R
    Expert Rev Med Devices; 2013 Mar; 10(2):247-56. PubMed ID: 23480093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulse Wave Velocity Predicts Response to Renal Denervation in Isolated Systolic Hypertension.
    Fengler K; Rommel KP; Hoellriegel R; Blazek S; Besler C; Desch S; Schuler G; Linke A; Lurz P
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28515119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beyond blood pressure: percutaneous renal denervation for the management of sympathetic hyperactivity and associated disease states.
    McArdle MJ; deGoma EM; Cohen DL; Townsend RR; Wilensky RL; Giri J
    J Am Heart Assoc; 2015 Mar; 4(3):e001415. PubMed ID: 25801757
    [No Abstract]   [Full Text] [Related]  

  • 38. Procedural Reassessment of Radiofrequency Renal Denervation in Resistant Hypertensive Patients.
    Rabbia F; Testa E; Fulcheri C; Berra E; Di Monaco S; Covella M; Pappaccogli M; Monticone S; Rosiello R; Rossato D; Veglio F
    High Blood Press Cardiovasc Prev; 2017 Jun; 24(2):187-192. PubMed ID: 28374154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catheter-based renal sympathetic denervation: a targeted approach to resistant hypertension.
    Gewirtz JR; Bisognano JD
    Cardiol J; 2011; 18(1):97-102. PubMed ID: 21305496
    [No Abstract]   [Full Text] [Related]  

  • 40. [Renal denervation - a novel therapeutic option for resistant hypertension?].
    Ritter A; Sudano Noll I; Suter PM
    Praxis (Bern 1994); 2014 Oct; 103(20):1169-78. PubMed ID: 25270745
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.